[1] Sarkar FH, Li Y.
Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treat Rev. 2009 Nov;35(7):597-607. Epub 2009 Aug 5.
[2] Zeligs MA. Safer Estrogen With Phytonutrition. Townsend Letter for Doctors and Patients. 1999; 189:83-88.
[3] Zeligs, MA. The Cruciferous Choice: Diindolylmethane or I3C? Phytonutrient Supplements For Cancer Prevention and Health Promotion.
Townsend Letterfor Doctors and Patients. August. 2001.
[4] Dalessandri KM, Firestone KM, Firestone GL, Fitch MD, et al. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutrition and Cancer. 2004;50(2):161-7.
[5] Zeligs MA, Brownstone PK, Sharp ME, et al. Managing Cyclical Mastalgia with Absorbable Diindolylmethane: A Randomized, Placebo-controlled Trial. JANA. Vol. 8, No.1 2005. Pages 10-20.
[6] Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-Hydroxyestrone: the 'good' estrogen. J Endocrinol. 1996;150 Suppl:S259-265.
[7] Chen DZ, Qi M, Auborn KJ, et al. Indole-3-Carbinol and Diindolylmethane Induce Apoptosis of Human Cervical Cancer Cells and in Murine HPV16-Transgenic Preneoplastic Cervical Epithelium. J Nutr. 2001 Dec;131(12):3294-3302.
[8] Zeligs MA, Sepkovic DW, Manrique C, et al. Absorption-enhanced 3,3’-Diindolylmethane: Human Use in HPV-related, Benign and Pre-cancerous Conditions
. Proc. Am. Assoc. Cancer Res. 2003, Apr; 44.
[9] Leong H, Firestone GL, Bjeldanes LF. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
Carcinogenesis. 2001 Nov;22(11):1809-17.
[10] Rahman KW, Sarkar FH. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Research 65. 2005 Jan 1;65(1):364-71.
[11] Rahman KW, Li Y, Wang Z, et al. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Research 6. 2006 May 1;66(9):4952-60.
[12] Miller, K. Estrogen and DNA Damage: The Silent Source of Breast Cancer? J Natl Cancer Inst. 2003 Jan 15;95(2):100-2.
[13] Zeligs, MA. The Doctor’s Research Update. Prostate Health Promotion with Diindolylmethane (DIM). 2008. Available at
; http://dimfaq.com/index.htm: Accessed May 1, 2008.
[14] Kong D, Yiwei L, Wang Z, et al. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Research 67. 2007 Apr 1;67(7):3310-9.
[15] Nachshon-Kedmi M, Yannai S, Fares FA. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway.
British Journal of Cancer (2004) 91
, 13581363.
[16] Schneider J. Effects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites.
J Clin Endocrinol Metab. 1983 May;56(5):973-8.
[17] Hershcopf RJ, Bradlow HL.
Obesity, diet, endogenous estrogens, and the risk of hormone-sensitive cancer. Am J Clin Nutr. 1987 Jan;45(1 Suppl):283-9.
[18] Zeligs, MA. The Doctor’s Research Update. Diindolylmethane (DIM) For Healthy Aging. 2008. Available at;
http://dimfaq.com/index.htm: Accessed May 1, 2008.
[19] Zeligs MA, Fulfs JC, Peterson R, et al. In vivo, uterine-protective activity of absorption-enhanced diindolylmethane: Animal and preliminary human use in combination with Tamoxifen. Proc Am Assoc Cancer Res. 2003. 44:1268.